Local firms gear up for new HIV/AIDS drug tender
New contract has cost implications for health department
21 July 2019 - 18:08
Local pharmaceutical companies are gearing up to bid for a supplementary HIV/AIDS drug tender, which includes a large supply contract for a key drug previously awarded mostly to importers.
The new contract also has cost implications for the health department, which says it will have to find an additional R223m to fund an extra 45.1-million packs of the three-in-one pill combining tenofovir, emtricitabine and efavirenz, known as TEE...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.